Abbott Labs Announces Executive and Director Changes
Ticker: ABT · Form: 8-K · Filed: 2024-11-15T00:00:00.000Z
Sentiment: neutral
Topics: executive-changes, board-changes, officer-departure
Related Tickers: ABT
TL;DR
Abbott Labs shakes up leadership: new directors elected, execs depart.
AI Summary
Abbott Laboratories announced on November 12, 2024, changes in its executive team. Specifically, the company reported the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for its key executives.
Why It Matters
Changes in key leadership positions can signal shifts in company strategy or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and stability.
Key Players & Entities
- ABBOTT LABORATORIES (company) — Registrant
- Illinois (state) — State of Incorporation
- ABT (ticker) — Common Stock Ticker
FAQ
What specific roles have been affected by the executive changes?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers,' but does not specify the exact roles in this summary.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on November 12, 2024.
What is Abbott Laboratories' state of incorporation?
Abbott Laboratories is incorporated in Illinois.
What is the ticker symbol for Abbott Laboratories' common stock?
The ticker symbol for Abbott Laboratories' common stock is ABT.
What is the primary business of Abbott Laboratories according to the filing?
The filing lists Abbott Laboratories' Standard Industrial Classification as 'PHARMACEUTICAL PREPARATIONS [2834]'.
From the Filing
0001104659-24-119717.txt : 20241115 0001104659-24-119717.hdr.sgml : 20241115 20241115161333 ACCESSION NUMBER: 0001104659-24-119717 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241112 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20241115 DATE AS OF CHANGE: 20241115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 241468019 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 8-K 1 tm2428216d1_8k.htm FORM 8-K false 0000001800 Common Shares, Without Par Value ABT 0000001800 2024-11-12 2024-11-12 0000001800 us-gaap:CommonStockMember exch:XCHI 2024-11-12 2024-11-12 0000001800 us-gaap:CommonStockMember exch:XNYS 2024-11-12 2024-11-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Common Shares, Without Par Value   ABT       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549       FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   November 12, 2024 Date of Report (Date of earliest event reported)     ABBOTT LABORATORIES (Exact name of registrant as specified in charter)       Illinois   1-2189   36-0698440 (State or other Jurisdiction   (Commission File Number)   (IRS Employer of Incorporation)       Identification No.)       100 Abbott Park Road Abbott Park , Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 224 ) 667-6100   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities Registered Pursuant to Section 12(b) of the Act:   Title of Each Class Trading Symbol(s) Name of Each Exchange  on Which Registered Common Shares, Without Par Value ABT New York Stock Exchange Chicago Stock Exchange, Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company   ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨             Item 5.02 Departure of Directors or Certain Officers; Election of Directors;